Skip to main content
. 2022 Feb 9;16(2):e0010096. doi: 10.1371/journal.pntd.0010096

Fig 3. Proportion of participants CFA positive (A) and Mf positive (B) by age-group and sex before receiving mass drug administration (baseline).

Fig 3

CFA, circulating filarial antigenemia; Mf, microfilariae.